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S)'naptic inhibition in brain is mainly mediated via GABA^ rc¢¢ptont which di~pl:ty a strikin~ strtt¢tural betero~tenCity. A novel type of GABA^ 
receptor subtmit. ~he 6.subtmit. has recently been described b=~d on molecular donin~l of'lt~ eDNA Ill. To identify the pre ealenee and distribution 
of GABA^ receptors which contain the 6.subunit protein in sltu polyclomd site.directed antiscm were developed altainsl thre~ synthetic pcptides 
derived rorm the rat 6-subtmit eDNA.:~equcnec, All anti~ra ~pccifically recognized a ~4 kDa protein i~ GABA^ receptor prepanttion~, Nearly 
30~ of the GA BA,,, reccptor~ contained tl~e 6.suhunit irnmunoreaetivity and displayed high affinity GABA and birth atllnity bcnzodiazepine bindinlt 
sites as ~hown by immunopt¢cipitation, Receptors which contain ~he di-subunit were irnmunohistochemically shown to be restricted to a few brain 
areas such as: the cerebellum, thalamus and dentate gyrus ol" the hippocampal formation, Thus. those neurons which express GABA^ receptors 
with a 6.sUbUnit have now been vimtalized arid made accessible for a functional analysis of ttlis GABA^ receptor subtype in situ, 
GABA^ receptor; ~$-Subunit; An  lpcptide antisera; Western btottlnlg lmmunc~precipitation; lmmunohistochemistry 
1. INTRODUCTION 
Inhibitory neurotransmission in mammalian brain is 
mainly mediated via GABA^ receptors. They constitute 
GABA-gated hetero-oligomeric eceptor-channel com- 
plexes wlfich can be allosterically modulated by various 
clinically important neuroaetive drugs, notably by 
ligands of the benzodiazepine r ceptor and by bar- 
biturates [2]. Despite their physiological and phar- 
macological relevance, the structure of GABA^ recep- 
tors is yet unresolved. Initial biochemical and im- 
munochenaical characterization f the GABA ~, receptor 
pointed to a 250 kDa 'eceptor complex consisting of a- 
and ~3-subunits (reviewed in [3]), Subsequent molecular 
cloning of the c~. and ,3-subunit cDNAs led to the 
discovery of not only multiple a- and B.subunit 
isoforms (at-6, /3~,31 but also of multiple 3,-subunits 
(3't- 2) and a +5.subunit (reviewed in [4-6]). To analyze 
the subunit composition of various GABAA receptor 
subtypes in situ, subunit-specific antibodies are being 
used. The a~-, c~2-, c~3-, u6-, "YZ- and ~32/.~-subunits were 
identified as proteins of 50, 53, 60, 57, 43 and 56/57 
kDa, respectively [7-18]. A frequent association of the 
c~-, 3z/~- and 3,z-subunits was recently demonstrated 
for GABAA receptors in situ [13] suggesting that this 
subunit combination is of physiological relevance. Co- 
expression of  this subunit combination (ect, /3z, 3,2) 
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resulted in GABA-gated chloride channels which were 
modulated by benzodiazepine receptor tigands [19,20]. 
In contrast to the a-,/~- and 3,-subuni~s, no information 
exists on the size, distribution and functional role of the 
8-subunit protein in situ. In recombinant receptors, this 
subunit, which was identi fled by molecular cloning[ 1 ], 
formed GABA-sensitive homo-oligomeric ion channels 
but failed to convey benzodiazepine receptor m dula.~ 
tion wheri co-expressed with o~- and B-subunits [1], 
However, it remained unclear to what extent the <3. 
subunit is a constituent of GABAA receptors in rico, 
possibly denoting receptor subtypes which lack certain 
modulatory responses to drugs. To approach this ques- 
tion we developed antisera gainst hree different pep- 
tide sequences unique to the 8-subunit and report here 
on the identification, size and distribution of  the ~5- 
subunit protein as integral component in a subset of 
GABAA receptors in vivo. 
2. MATERIALS AND METHODS 
Three subunit-specif[c peptides derived from the rat ~5-subunit 
eDNA sequence [I] were synthesized: peptide 6(1-17)(sequence 
pyroglutamyl-PH HGARAMNDIGNYVG), peptide 6(179-189) (se- 
quence YWSENQEQ1HG) and peptide //(316-322) (sequence 
HFNADYR) [21,22]. An additional cysteine was added to the C- 
terminus (peptides 6(1-17) and 6(179-189)) or N.terminus (peptide 
6(316-322)), For antibody production the peptides were coupled via 
the additional cy~teine tokeyhole timpet haemocyanine (KLH) [23] 
and about 100 og conjugate mulsified 1:2 in Freund's complete adju- 
vant were used for immunization of rabbits (KOHA strain, BRL) as 
described previously [12-131. The development of an immune 
response was monitored by enzyme-linked immunosorbent assay 
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3. RESULTS AND DISCUSSICN 
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brain WRJ subjwrd Iu SDS~PAGE UIJ pnral l’l=tjftumrtnmil bintlintl 
To identify the size and prevalence of the Q-subunit as 
Vtlcl prr lane) :~fltt blrrirccl anlo niirucelluluro nhcrin for inrmunwdn~ 
ing with vnrluux 6.xubI~IrlI.~pCriTiL wnrirerti, (Lnnc I-2): &l-11)- 
constituent of GABAh reccptars in vivo polyclonal an- z\ntisrr\lrn (t:ltNO9 in [Ire nbxcncc (hrnt: I) err prrxent~ (lone: 2) 01’ lo 
tisera were raised against hree different cDN&dcrivcd &l-d pepride 6(l-17). (Lnnc 3-4): 6(171)-1;dc))~snri$ernnr (I: IW in 
peptide sequences unique to the rat &subunit. The N- 111~ rbdenuc (tnnc 3) ar prcncnsr Llanr 4) ur JO rw+ml tqxkk 
terminal. pcptide (residues I-17), as well as a pcptide d(l7GISr)), (tnnc 5-6): d(3 Ib-f22I.nrrtircrtrll1 (l:INKl) in the abrsnrc 
from the proposed extracellular domain (residues 
(Inoc S) (31 prcrcnee (low 6) al 30 fig/ml pcpllttc 6(316-322). 
179-189) and a pepcide from the proposed intracellular 
loop located between the transmembrane spanning ding and 21 f 6ofo (n = 3) of [lH]muscimol binding. The 
regions M3 and M4 (residues 316-322) were synthcsizcd specificity of the immune reaction was 9sscssed in pep- 
and coupled to KLH and used as antigens, High titer tide competition experiments. When increasing concen- 
antisera were already obtained two weeks after the first trations of the pcptidc 6(1-17). were added to the 
booster injection as tested in ELISA using the respcc- a( I-17)-antiserum the immunoprccipitation of GAB& 
tive peptidcs as antigens. receptors was prcvcntcd in a dose-dependent manncc 
To identify the size of the &subunit protein GABA,, (Fig. 2B). Thus, a subpopulation of nearly 30% of 
receptors purified from whole rat brain were tested with GABA,, receptors appears to contain the J-subunit, 
the antisera on Western blots. All three antisera selcc- To determine the regional distribution of the S- 
tively recognized a 54 kDa polypeptidc (Fig. I, lanes subunit protein, crude membrane fractions from dif- 
1,3,5). Co-incubation of the antisera with the rcspcctivc 
peptides blocked the immune reaction in all three cases 
documenting the specificity of the antibody reactions 
a B 
(Fig. 1, lanes 2,4,6). The apparent size of the native 100 
100 - FE 
protein (54 kDa) exceeds that of the deduced amino acid g oo %:g 2% so- 
sequence of the &subunit cDNA (49 kDa) [I] suggesting ,= g 6. 
,I g 
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that a carbohydrate moiety may be attached at one or P 2” eo- m” ,o
both potential N-linked glycosylation sites withirt the S- 0 4~ E0 
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subunit sequence contributing to the apparent ‘Z E Y 
molecular size of the native protein, 
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Two of the antisera, the &l-17)- and the 6(179-189)- 
antiserum, recognized the d-subunit in the native con- 30 60 90 120 150 .E .7 .6 .5 .4 .3 
formation as demonstrated by immunoprecipitation cx- 6 (1~17)~Anliserum @I] log (MIS (1.17) PeptIde 
periments. As illustrated for the b(l-17)~antiserum, in- Fig. 2. lmmunoprecipitation of purified CAB&, receptors from rat 
cubation of purified GABAA receptor preparations brain with purified 6(1-17)~antiserum. (A) GAUAA receptor (150-200 
with increasing concentrations of the antiserum resulted frnol [3W)flumazcnil binding) was incubated with increasing concen- 
in saturable immunoprecipirarion f GABA+, receptors trations of antiserum and [“I-I]flumarenil binding was determined in 
ag monitored by [3H]flumazenil and [‘Hlmuscimoi the supernntant (0) and the precipitate (e) in triplicate in at least 
radioligand binding (Fig. 2A). A maximum of 28 3- 7% 
three different experiments (means ?r SD). Control values, for which 
01 = 7) of I’H]flumazenil binding and 26 -+. 6% (n = 5) of 
the anrkerum was replaced by preimmune serum or by buffer, were 
subtracted. (B) The specificity of the immunoprecipitation was deter- 
[3H]muscimol binding was precipitated with the mined by incubating the 6(l-17)-antiserum at a concentration leading 
6( l-1 “I)-antiserum. Similar results were obtained with to maximum immunoprccipitation in the presence of increasing con- 
the 6(179-189)-antiserum which yielded a maximum 
centrations of the &I-17).pcptide or in the absence of the pcptide 
(100% value). Specific binding of [3H]flumazenil was determined in 
precipitation of 30 I 2% (n = 4) of [3H]flumazenil bin- three different experiments (@,O, A). 
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ferent brm=tin areas were analyzed for immunoreactivity 
in Western blo|s, In membrane~ or' all brain regions ex.  
amined, a sinille protein band of 54 kDa was labeled 
with zinc ~(|-lT).anttserum, confirmin~ the results ob- 
tained with the purified GABA^ receptors (Fil3, 3), 
Although the ~.subunit immunoreactivily was present 
in all brain regions examined the intensities of signals 
varied. Strongest labdint~ was observed in the cere- 
bellum followed by thalamuslhypothalamus, olfactory 
bulb and cerebral cortex, whereas weaker signals were 
detected in the striatum, hippocampal formation and 
brainstem. 
To quantify the amount of GABA^ receptors that con- 
tain the ~-subunit n the various brair~ re,ions immuno. 
precipitation experiments were performed using crude 
deoxycholate extracts of brain membranes (Table 1). 
The amount of GABA^ receptor precipitated from ex- 
tracts of whole brain (21 ± 2o10 [~Hlflumazenil binding, 
n = 3)was  slightly lower than that precipitated from 
purified GABA^ receptor preparations (nearly 30070). 
In line with the regional prevalence of the 8-subunit 
detected in Western blots, highest immunoprecipitation 
was observed in extracts of the olfactory bulb, cere- 
bellum and thalamus/hypothatamus, whereas in the 
cerebral cortex, striatum and hippocampal formation 
significantly less receptor was precipitated (Table l). 
These results uggest that the 5-subunit protein may be 
differentially expressed in various brain regions. 
To identify those neuronal populations that express 
GABA^ receptors containing the ~5-subunit, mmuno- 
histochemical experiments were performed + in para- 
sagittal cryostat sections of rat brain. The ~-subunit m. 
munoreactivity was most abundant in the granular layer 
of the cerebellum with mainly somatic staining in a 
subset of cells (Fig. 4D), followed by thalamus, dentate 
gyrus of the hippocampal formation and olfactory 
tubercle (Fig. 4A) In other brain regions, e.g. olfactory 
bulb, caudate putamen, ventral pallidum and cerebral 
cortex, only weak staining was detected (Fig. 4A).:The 
specificity of immunostaining was assessed in peptide 
competition experiments. When the peptide 5(1-17) was 
added to the antiserum prior to the incubation pro- 
cedure no immunostaining was observed (Fig. 4B). In 
general, the intensity of the ~-subunit signal observed 
immunohistochemically in various brain regions was in 
congruence with that obtained by Western blotting or 
immunoprecipitation. Furthermore, the immunostain- 
ing pattern of the ~5-subunit protein (Fig. 4A) correlated 
well with the expression pattern of the 5-subunit mRNA 
[1]. For instance, in the hippocampal formation, the 
immunoreactivity of the dendritic area of the granule 
cells of the dentate gyrus (Fig. 4A,C) is correlated with 
the in situ hybridization signals in the corresponding 
cell body layer [1]. Likewise, in the cerebellum, strong 
immunoreactivity was displayed by the granular layer 
(Fig. 4A) which also showed very high in situ hybridiza- 
tion histochemistry signals for the ~5-subtmit mRNA [1]. 
p + 
kDa 
~ ~ ~ +~ . . . . . . .  ~ ~ ' 5 4  
Fi~, 3, I~,¢lllional distribution or the 6,~ubmlit immunore~tivity deter- 
mined by We~z~rn blotlit~lt. An equ= numl~er of [)Hlllmlnaxenil bin. 
dtl~M ~t|e~ '- 6Q fmol) from erutl¢ membrane fr~elion~ l~o|ated from 
~evernt brain area~ were applied to eael~ lan~ and tact+bated wtlh the 
/~179-189).antiserum (dlluted I:1000)+ 
In the molecular layer no signals could be detected 
either immunohistocl~emically (Fig. 4D) or by in situ 
I~ybridization histochemistry [1]. 
The ~5-subunit protein is most prominently expressed 
in the cerebellar granular layer, an area which is 
characterizedby high levels of high affinity muscimol 
binding and low levels of benzodiazepine receptor bin- 
ding [26]. It had therefore been suggested that the cS- 
subunit may constitute a GABAA receptor subtype that 
lacks high affinity benzodiazepine binding sites [1]. 
This was supported by the observation that the ~- 
subunit, :when co-expressed with ~- and/3-subunits, was 
not able to confer high affinity benzodiazepine binding 
to recombinant GABA~ receptors [11. However, our 
immunoprecipitation data clearly show that GABAA 
receptors which contain the ~5-subunit immunoreactivity 
display bot!~ high affinity GABA sites and high affinity 
benzodiazepine binding sites in all brain areas tested. 
Since functional benzodiazepine receptors are 
generated it~ recombinant receptors by co-expression f
a-, ~3-and ./z-subunits, it is conceivable that the 8- 
subunit may be associated with a-,/3- and 7z-subunits in
Table I 
lmmunoprecipitation of GABAA receptors containing the ~-subunit 
from crude deoxycholate extracts of various regions of rat brain 
Brain Region [~H]Flumazenil binding sites 
precipitated (%) 
Olfactory bulb 28 ~- 5 
Cerebellum 23 ± 3 
Thalamus/hypothalamus . 22 :t: 3 
Cerebral cortex t7 ± 3 
Striatum 17 ± 3 
Hippocampus 15 ± 3 
Deoxycholate extracts from membranes of various brain areas (200 
jd) were incubated with an amount of ~(179-189)-antiserurri (t0 #l) 
which leads to ma×imum i munoprecipitation. The results are ex- 
pressed as percentage of specific ['~H]flumazenil binding; 100% values 
correspond to the sum of the radio|igand binding in the im- 
munoprecipitate nd in the corresponding supernatant. Nonspeeific 
immunOprecipitation wasdetermined by replacing the antiserum by 
preimmune s rum or buffer. The values are means _ SD from three 
experiments analysed in tri plicateS. 
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Fig. 4. I mmunohistochemical localization of- 8-subunit mmunoreactivity n parasagittal rat brain sections incubated witl~ affinity-purified ~(1- t7)- 
antiserum (diluted 1:10). (A,B) Macroscopic view of staining in the absence (At and presence (B) of 60 tag/rnl peptide 8(1-17). (C) lmmunostaining 
in the thalamus and the hippocampal formation. (D) Microscopic view of cerebellar stainhtg. Note he intense staining in cerebellar granule cells 
and the lack of staining in the Pt, rkinje cell layer and the molecular layer. Positive signals tn (A,B,C) correspond to the wlfite areas, in (D) to tire 
black areas. Bars: (A,B) 2,0 ram; (C) 0.8 mm; (D) 20 tma. Abbreviations: Cx, cerebral cortex: 13, dentate gyrus; H, hippocampus; G, granular layer: 
M, molecular layer; Ob, olfactory bulb; P, Purkinje cells; T, thalamus. 
vivo. This view is supported by the strong immunoreac- 
tivity in the cerebellar granular layer observed not only 
for  the 8-subunit but also for the c~ ~,, B2/3 and -/2-sub- 
unit proteins [13,15]. 
In summary, we have demonstrated that the 8- 
subunit is an integral protein o f  54- kDa in a subset of  
native GABAA receptors comprising up to  30% of  
GABAA receptors in different brain areas. Neuronal 
populations which express the 8-subunit were identified 
immunohistochemically in situ ancl are now amenable 
to a functional analysis of this GABAA receptor sub- 
type. Mapping the various subunit combinations i  part 
of the attempt o establish a structure/function rela- 
tionship for the various GABAA receptor subtypes in 
the brain. 
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